{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360574094728512384.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s1074-5521(00)00134-4"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1074552100001344?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1074552100001344?httpAccept=text/xml"}},{"identifier":{"@type":"NAID","@value":"30003233943"}}],"dc:title":[{"@value":"Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1583668925919250560","@type":"Researcher","foaf:name":[{"@value":"J Rahuel"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512386","@type":"Researcher","foaf:name":[{"@value":"V Rasetti"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512257","@type":"Researcher","foaf:name":[{"@value":"J Maibaum"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512259","@type":"Researcher","foaf:name":[{"@value":"H Rüeger"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512256","@type":"Researcher","foaf:name":[{"@value":"R Göschke"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512260","@type":"Researcher","foaf:name":[{"@value":"N-C Cohen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512388","@type":"Researcher","foaf:name":[{"@value":"S Stutz"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512385","@type":"Researcher","foaf:name":[{"@value":"F Cumin"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512384","@type":"Researcher","foaf:name":[{"@value":"W Fuhrer"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512387","@type":"Researcher","foaf:name":[{"@value":"JM Wood"}]},{"@id":"https://cir.nii.ac.jp/crid/1380574094728512258","@type":"Researcher","foaf:name":[{"@value":"MG Grütter"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10745521"},{"@type":"NCID","@value":"AA11072585"}],"prism:publicationName":[{"@value":"Chemistry & Biology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2000-07","prism:volume":"7","prism:number":"7","prism:startingPage":"493","prism:endingPage":"504"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1074552100001344?httpAccept=text/plain"},{"@id":"https://api.elsevier.com/content/article/PII:S1074552100001344?httpAccept=text/xml"}],"createdAt":"2002-07-25","modifiedAt":"2025-10-21","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002219111026048","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Amino Acid Derived Epoxide Ring Opening under Microwave Irradiation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004230378886144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232016682496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204169423104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Renin Inhibitors Containing Pseudodipeptidic Units in P3-P2 and P1-P1' Positions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679140891520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Renin Inhibitors with Pseudodipeptidic Units in P1-P1' and P2'-P3' Positions."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679252924800","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The pharmacological profile and clinical findings on aliskiren (Rasilez tablet), direct renin inhibitor"},{"@language":"ja","@value":"直接的レニン阻害薬アリスキレン（ラジレス）の薬理学的特長および臨床試験成績"},{"@value":"新薬紹介総説 直接的レニン阻害薬アリスキレン(ラジレス)の薬理学的特長および臨床試験成績"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ チョクセツテキ レニン ソガイヤク アリスキレン ラジレス ノ ヤクリガクテキ トクチョウ オヨビ リンショウ シケン セイセキ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680232197504","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Successful Treatment of Hypertension in Anuric Hemodialysis Patients with a Direct Renin Inhibitor, Aliskiren"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238096747776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"RENIN ANGIOTENSIN SYSTEM-DEPENDENT AND -INDEPENDENT FUNCTIONS OF (PRO)RENIN RECEPTOR AND THE ROLES OF ITS BLOCKERS"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713071869184","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"RENIN ANGIOTENSIN SYSTEM IN THE CONTEXT OF RENIN, PRORENIN, AND THE (PRO)RENIN RECEPTOR"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750865145216","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Mechanistic insights into the antifibrotic activity of aliskiren in the kidney"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572701190890112","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387451056562048","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842050541312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s1074-5521(00)00134-4"},{"@type":"CIA","@value":"30003233943"},{"@type":"CROSSREF","@value":"10.1007/5584_2018_179_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1248/cpb.53.1305_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1246/cl.2007.648_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1007/s10157-012-0601-y_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1254/fpj.135.159_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.2185/jrm.6.26_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.7831/ras.1.43_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1248/cpb.50.850_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.7831/ras.2.37_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"},{"@type":"CROSSREF","@value":"10.1016/j.bmcl.2012.05.092_references_DOI_U2PrPlyOTJtc5Vz1hGpZQVmaOHT"}]}